Anthropic has warned that recursive-self-improving AI could be on the horizon, but the truth is the company is more ...
Sakana AI has opened a Recursive Self-Improvement Lab to test whether AI systems can help redesign and optimize future AI systems, a bet aimed at reducing frontier AI’s dependence on brute-force ...
The maker of Claude wants AI labs, including itself, to prepare for a coordinated slowdown if models begin building their own ...
Native scavengers may be exploiting Burmese python nests to their benefit but it's unclear how often it is happening.
First AI zero-day: Google detected the first confirmed AI-created zero-day exploit, aimed at bypassing 2FA in a popular ...
Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate the creation of artificial intelligence. By Cade Metz Reporting from San ...
Scientists discovered a way to lure invasive Burmese pythons that have upset Florida’s ecosystem, including the Everglades.According to a 2023 report by Southern Illinois University, in September 2022 ...
Scientists use raccoons, possums with tracking devices to locate invasive Burmese pythons in Florida
Pythons are not the easiest animals to find. This well camouflaged and secretive species is able to blend perfectly into the environment. Detection rates for pythons are low, and on average it takes ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. logos of OpenAI There’s interesting news coming from Sam Altman’s empire, a firm known for ...
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the 11 most popular AI penny stocks to buy now. On February 25, Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) reported Q4 revenue of $35.5 million ...
Two sources familiar with the U.S. military's use of artificial intelligence confirm that the U.S. used Anthropic's Claude AI model over weekend for the attack on Iran — and is still using it. The ...
Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results